HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu-Tang Chin Selected Research

nano-diamino-tetrac

1/2020NDAT Targets PI3K-Mediated PD-L1 Upregulation to Reduce Proliferation in Gefitinib-Resistant Colorectal Cancer.
12/2018Enhancement by Nano-Diamino-Tetrac of Antiproliferative Action of Gefitinib on Colorectal Cancer Cells: Mediation by EGFR Sialylation and PI3K Activation.
10/2018Nano-Diamino-Tetrac (NDAT) Enhances Resveratrol-Induced Antiproliferation by Action on the RRM2 Pathway in Colorectal Cancers.
10/2018Nano-diamino-tetrac (NDAT) inhibits PD-L1 expression which is essential for proliferation in oral cancer cells.
10/2016Actions of l-thyroxine and Nano-diamino-tetrac (Nanotetrac) on PD-L1 in cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu-Tang Chin Research Topics

Disease

24Neoplasms (Cancer)
07/2020 - 12/2014
9Colorectal Neoplasms (Colorectal Cancer)
07/2020 - 01/2016
6Gingival Overgrowth
04/2021 - 12/2005
6Inflammation (Inflammations)
03/2021 - 12/2005
5Periodontitis
02/2022 - 10/2013
5Mouth Neoplasms (Oral Cancer)
07/2020 - 10/2018
4Ovarian Neoplasms (Ovarian Cancer)
11/2019 - 04/2017
3Colonic Neoplasms (Colon Cancer)
01/2020 - 01/2018
3Breast Neoplasms (Breast Cancer)
10/2016 - 12/2014
2Neoplasm Metastasis (Metastasis)
07/2020 - 01/2018
2Obesity
11/2019 - 05/2016
2Thyroid Neoplasms (Thyroid Cancer)
01/2017 - 05/2016
2Periodontal Diseases (Periodontal Disease)
10/2016 - 10/2013
1Wounds and Injuries (Trauma)
03/2021
1Hepatocellular Carcinoma (Hepatoma)
11/2019
1Myoma
10/2018
1Leiomyoma (Uterine Fibroids)
10/2018
1Prostatic Neoplasms (Prostate Cancer)
02/2018
1Hyperglycemia
01/2018
1Carcinogenesis
01/2018
1Cardiovascular Diseases (Cardiovascular Disease)
09/2017
1Neurodegenerative Diseases (Neurodegenerative Disease)
09/2017
1Carcinoma (Carcinomatosis)
10/2016
1Anaplastic Thyroid Carcinoma
05/2016
1Alveolar Bone Loss
01/2015

Drug/Important Bio-Agent (IBA)

13Thyroid HormonesIBA
07/2020 - 01/2016
13ResveratrolIBA
02/2020 - 12/2014
12IntegrinsIBA
09/2019 - 12/2014
10Proteins (Proteins, Gene)FDA Link
03/2021 - 12/2005
8Thyroxine (Levothyroxine)FDA LinkGeneric
10/2019 - 10/2016
7Cyclosporine (Ciclosporin)FDA LinkGeneric
04/2021 - 12/2005
6tetraiodothyroacetic acid (TA(4))IBA
07/2020 - 01/2016
5nano-diamino-tetracIBA
01/2020 - 10/2016
5Cell Surface ReceptorsIBA
09/2019 - 12/2014
4CytokinesIBA
03/2021 - 05/2016
4LeptinIBA
11/2019 - 05/2016
4B7-H1 AntigenIBA
10/2019 - 10/2016
4Messenger RNA (mRNA)IBA
10/2018 - 05/2006
3Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
10/2018 - 01/2018
3leptin (116-130)IBA
07/2017 - 05/2016
3Matrix Metalloproteinases (MMPs)IBA
10/2016 - 10/2013
2Reactive Oxygen Species (Oxygen Radicals)IBA
04/2021 - 01/2018
2Pharmaceutical PreparationsIBA
07/2020 - 01/2019
2Gefitinib (Iressa)FDA Link
01/2020 - 12/2018
2Peptides (Polypeptides)IBA
11/2019 - 07/2017
2CateninsIBA
01/2018 - 01/2018
2Hormones (Hormone)IBA
01/2018 - 01/2017
2Dihydrotestosterone (Androstanolone)IBA
01/2017 - 11/2015
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2016 - 12/2005
1SilkFDA Link
02/2022
1AntioxidantsIBA
04/2021
1SiliconesIBA
03/2021
1Conditioned Culture MediaIBA
03/2021
1Biological ProductsIBA
07/2020
1heteroneminIBA
07/2020
1Hematoxylin (Haematoxylon)IBA
01/2020
1Eosine Yellowish-(YS) (Eosin)IBA
01/2020
1Coloring Agents (Dyes)IBA
01/2020
1Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
10/2018
1Insulin-Like PeptidesIBA
10/2018
1StilbenesIBA
10/2018
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2018
1Metformin (Glucophage)FDA LinkGeneric
01/2018
1Free RadicalsIBA
01/2018
1Blood Glucose (Blood Sugar)IBA
01/2018
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2018
1PolyphenolsIBA
09/2017
1Follicle Stimulating Hormone (Follitropin)FDA Link
07/2017
1Antineoplastic Agents (Antineoplastics)IBA
07/2017
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
07/2017
1Mitogen-Activated Protein Kinase 3IBA
04/2017
1Phosphotransferases (Kinase)IBA
01/2017
1Estrogens (Estrogen)FDA Link
01/2017
1LigandsIBA
01/2017
1Plant ExtractsIBA
01/2017
1Tn antigenIBA
09/2016
1AntigensIBA
09/2016
1CarbohydratesIBA
09/2016
1Polysaccharides (Glycans)IBA
09/2016
1MucinsIBA
09/2016
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
05/2016
1Cetuximab (Erbitux)FDA Link
01/2016
1Complex MixturesIBA
01/2016
1Fulvestrant (Faslodex)FDA Link
11/2015
1GelatinasesIBA
01/2015
1Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
01/2015
1Estrogen ReceptorsIBA
12/2014
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
06/2014
1TeaIBA
06/2014
1Bacterial AntigensIBA
10/2013
1BerberineIBA
10/2013
1Immunosuppressive Agents (Immunosuppressants)IBA
03/2013
1SolutionsIBA
03/2013
1ChlorhexidineIBA
03/2013

Therapy/Procedure

5Therapeutics
01/2020 - 01/2018
4Ligation
01/2017 - 10/2013
1Sutures (Suture)
02/2022
1Drug Therapy (Chemotherapy)
01/2020
1Chemoprevention
01/2018
1Organ Transplantation
03/2013